Chief of Division of Endocrinology; Associate Professor; Dept of Internal Medicine and Medical Education; Dell Medical School | The University of Texas at Austin
BIOGRAPHY
Speaker
Event Date & Time
Date: November 13, 2024
Time: 8:00 AM (PST), 11:00 AM (EST), 5:00 PM (CET)
Abstract
According to the CDC, in the United States, approximately 14.7% of adults have Diabetes, and another 10.8% have prediabetes. Unfortunately, as many as 8.7 million adults aged 18 years or older who met laboratory criteria for diabetes were not aware of or did not report having diabetes- limiting their opportunity for treatment and intervention before complications arise. By understanding the populations most at risk for Type 2 DM, we may have the opportunity to target screening programs and reduce the damage from this prevalent disease. In this webinar, Dr Mrinalini Kulkarni-Date, Chief of Endocrinology at Dell Medical School , The University of Texas at Austin will share her insights as to population at highest risk of Type 2 Diabetes and Pre-Diabetes and the characteristics of programs successful in bettering these statistics.
Learning Objectives
- Understand screening criteria in type 2 diabetes and pre-diabetes
- Identify patient populations that are high risk for diabetes and pre-diabetes
- Recognize the impact of social determinants of health on diabetes
- Discuss the elements of successful screening programs
References:
1. Centers for Disease Control and Prevention. Appendix A: Diabetes Data & Research. Accessed October 16, 2024. https://www.cdc.gov/diabetes/php/data-research/appendix.html
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...